Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPEAR: Half-Normal vs Normal Saline in PEA Cardiac Arrest
NCT05283850Phase 3Recruiting
- Start
- Feb 2022
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 3 trial of sodium chloride in pulseless electrical activity (PEA). Started Feb 2022; status: recruiting.
02
Drugs
sodium chloride
03
Conditions
pulseless electrical activity (PEA)
Beyond the preview
Go deeper on NCT05283850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283850.